Insider Buy/Sell Details for the Healthcare Sector — May 2026
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1930)
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
Chacon Quiros Juan Jose — Director
Shares
41,265
Price
$70.52
Total Value
$2.91M
Shares Held After
1,066,239
% of Holdings
3.7%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
58,394
Price
$0.73
Total Value
$42.63K
Shares Held After
1,727,293
% of Holdings
3.3%
Ultragenyx Pharmaceutical Inc. (RARE)
Horn Howard — Chief Financial Officer
Shares
4,683
Price
$24.90
Total Value
$116.61K
Shares Held After
110,342
% of Holdings
4.1%
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Sabag Mark — See "Remarks"
Shares
144,180
Price
$34.99
Total Value
$5.05M
Shares Held After
80,760
% of Holdings
64.1%
Moderna, Inc. (MRNA)
Hussain Abbas — Director
Shares
5,682
Price
$46.63
Total Value
$264.95K
Shares Held After
12,066
% of Holdings
32.0%
Emergent BioSolutions Inc. (EBS)
DeGolyer Donald W — Director
Shares
954
Price
$8.96
Total Value
$8.55K
Shares Held After
129,721
% of Holdings
0.7%
Emergent BioSolutions Inc. (EBS)
DeGolyer Donald W — Director
Shares
14,527
Price
$8.36
Total Value
$121.45K
Shares Held After
130,675
% of Holdings
10.0%
Emergent BioSolutions Inc. (EBS)
Zoon Kathryn C — Director
Shares
1,057
Price
$8.97
Total Value
$9.48K
Shares Held After
79,941
% of Holdings
1.3%
Emergent BioSolutions Inc. (EBS)
Zoon Kathryn C — Director
Shares
16,145
Price
$8.36
Total Value
$134.97K
Shares Held After
80,998
% of Holdings
16.6%
Emergent BioSolutions Inc. (EBS)
Dayal Sujata Tyagi — Director
Shares
980
Price
$8.94
Total Value
$8.76K
Shares Held After
100,563
% of Holdings
1.0%
Emergent BioSolutions Inc. (EBS)
Dayal Sujata Tyagi — Director
Shares
12,781
Price
$8.36
Total Value
$106.85K
Shares Held After
101,543
% of Holdings
11.2%
SANUWAVE Health, Inc. (SNVW)
Opaleye Management Inc. — 10% Owner
Shares
500
Price
$16.11
Total Value
$8.06K
Shares Held After
5,000
% of Holdings
9.1%
SANUWAVE Health, Inc. (SNVW)
Opaleye Management Inc. — 10% Owner
Shares
10,081
Price
$16.11
Total Value
$162.41K
Shares Held After
853,569
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,362
Price
$571.95
Total Value
$779.00K
Shares Held After
40,513
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,197
Price
$571.22
Total Value
$1.83M
Shares Held After
41,875
% of Holdings
7.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,621
Price
$570.28
Total Value
$2.06M
Shares Held After
45,072
% of Holdings
7.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
843
Price
$569.18
Total Value
$479.82K
Shares Held After
48,693
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
197
Price
$568.37
Total Value
$111.97K
Shares Held After
49,536
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$567.17
Total Value
$45.37K
Shares Held After
49,733
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$565.78
Total Value
$113.16K
Shares Held After
49,813
% of Holdings
0.4%
DANAHER CORP /DE/ (DHR)
SPOON ALAN G — Director
Shares
1,358
Price
$174.67
Total Value
$237.21K
Shares Held After
124,094
% of Holdings
1.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
2
Price
$714.13
Total Value
$1.43K
Shares Held After
17,503
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
1
Price
$712.09
Total Value
$712.09
Shares Held After
17,505
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
5
Price
$711.49
Total Value
$3.56K
Shares Held After
17,506
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
2
Price
$710.87
Total Value
$1.42K
Shares Held After
17,511
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
6
Price
$709.45
Total Value
$4.26K
Shares Held After
17,513
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
4
Price
$707.40
Total Value
$2.83K
Shares Held After
17,519
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
7
Price
$706.74
Total Value
$4.95K
Shares Held After
17,523
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
14
Price
$705.56
Total Value
$9.88K
Shares Held After
17,530
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
15
Price
$704.28
Total Value
$10.56K
Shares Held After
17,544
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
24
Price
$703.46
Total Value
$16.88K
Shares Held After
17,559
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
15
Price
$702.46
Total Value
$10.54K
Shares Held After
17,583
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
5
Price
$701.76
Total Value
$3.51K
Shares Held After
17,598
% of Holdings
0.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
23
Price
$160.00
Total Value
$3.68K
Shares Held After
3,666
% of Holdings
0.6%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
38
Price
$159.08
Total Value
$6.04K
Shares Held After
3,689
% of Holdings
1.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
65
Price
$158.35
Total Value
$10.29K
Shares Held After
3,727
% of Holdings
1.7%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
106
Price
$157.45
Total Value
$16.69K
Shares Held After
3,792
% of Holdings
2.7%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
82
Price
$156.24
Total Value
$12.81K
Shares Held After
3,898
% of Holdings
2.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
346
Price
$155.48
Total Value
$53.79K
Shares Held After
3,980
% of Holdings
8.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
288
Price
$154.38
Total Value
$44.46K
Shares Held After
4,326
% of Holdings
6.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
52
Price
$153.89
Total Value
$8.00K
Shares Held After
4,614
% of Holdings
1.1%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Krasney Karen — EVP, GENERAL COUNSEL
Shares
25,000
Price
$31.70
Total Value
$792.55K
Shares Held After
30,547
% of Holdings
45.0%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Bergmann Anthony — CHIEF FINANCIAL OFFICER
Shares
25,000
Price
$31.70
Total Value
$792.54K
Shares Held After
8,223
% of Holdings
75.2%
Travere Therapeutics, Inc. (TVTX)
Baynes Roy D. — Director
Shares
9,750
Price
$44.22
Total Value
$431.14K
Shares Held After
37,500
% of Holdings
20.6%
908 Devices Inc. (MASS)
Kenneweg John — SVP, Sales & Product Marketing
Shares
7,787
Price
$6.83
Total Value
$53.19K
Shares Held After
76,039
% of Holdings
9.3%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
15,857
Price
$65.00
Total Value
$1.03M
Shares Held After
58,555
% of Holdings
21.3%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
10,000
Price
$4.16
Total Value
$41.59K
Shares Held After
3,072,000
% of Holdings
0.3%
CHEMED CORP (CHE)
MCNAMARA KEVIN J — Director
Shares
2,000
Price
$421.13
Total Value
$842.26K
Shares Held After
90,219
% of Holdings
2.2%
Vir Biotechnology, Inc. (VIR)
SATO VICKI L — Director
Shares
22,000
Price
$10.05
Total Value
$221.03K
Shares Held After
1,078,391
% of Holdings
2.0%
Anika Therapeutics, Inc. (ANIK)
HENNEMAN JOHN B III — Director
Shares
5,000
Price
$14.66
Total Value
$73.32K
Shares Held After
54,871
% of Holdings
9.1%
Showing 1851–1900 of 1930 transactions (page 38 of 39)